Mimedx (MDXG) Capital Expenditures (2011 - 2026)

Mimedx has disclosed Capital Expenditures across 16 years of filings, most recently posting $598000.0 for Q2 2026.

• In Q2 2026, Capital Expenditures rose 234.08% year-over-year to $598000.0; the TTM figure through Jun 2026 stood at $1.6 million (up 66.16% YoY), while the FY2025 annual figure was $1.0 million, down 38.62% from the prior year.
• Capital Expenditures came in at $598000.0 for Q2 2026 at Mimedx, up from $570000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $1.1 million in Q1 2024 to a low of $105000.0 in Q2 2024.
• Average Capital Expenditures over 5 years is $410277.8, with a median of $363000.0 recorded in 2022.
• Year-over-year, Capital Expenditures slumped 93.92% in 2022 and soared 436.44% in 2023.
• Over 5 years, Capital Expenditures stood at $667000.0 in 2022, then tumbled by 35.98% to $427000.0 in 2023, then slumped by 38.41% to $263000.0 in 2024, then rose by 8.37% to $285000.0 in 2025, then surged by 109.82% to $598000.0 in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $598000.0 in Q2 2026, $570000.0 in Q1 2026, and $285000.0 in Q4 2025.